Transform Your Practice Schedule a Personalized Demo Today
Equip your practice with the first FDA-cleared AI for skin cancer detection. Drive new revenue and increase patient volume with a low-impact subscription. No hardware fees required.
- Detect 3 top skin cancers with 96% sensitivity*
- FDA-cleared results in seconds
- Reimbursement assistance available now
* Clinical evidence upon request.
Elevate Your Standard of Care Schedule a Personalized DermaSensor Demo
Boost practice revenue and patient confidence with FDA-cleared AI. Immediate non-invasive results. No hardware fees.
Many physicians currently refer patients out because they lack the diagnostic confidence to evaluate suspicious lesions on the spot. A personalized DermaSensor demo will show you how our FDA-cleared AI provides the objective certainty needed to keep patients in-house, allowing you to capture potential new revenue streams for your practice.
- Financial Advantage: Our low monthly subscription model replaces heavy capital expenses with no upfront hardware fees.
- Rapid Return: Monthly subscription costs can be covered by scanning just a few patients.
- Immediate Integration: A 30-minute onboarding session ensures your team is ready to meet the surge of proactive skin checks this Skin Cancer Awareness Month.
- Close the Gap: Join the initiative to detect more skin cancers at the point of care and avoid missed opportunities for your patients.
Schedule your demo today to discover how easy it is to integrate DermaSensor into your clinical workflow.
Explore How DermaSensor is Transforming Skin Cancer Assessments
Clinical Highlights:
- Detect 3 top skin cancers with 96% sensitivity*
- FDA-cleared results in seconds
- Reimbursement assistance available now
* Clinical evidence upon request.
As Featured In
Intuitive Three-Step Process From First Recording to the Result in 30 Seconds
Step 1
Identify lesion suggestive of skin cancer on the patient.
Step 2
Apply the handheld DermaSensor device to the lesion and initiate first recording. A total of five spectral recordings are taken from the skin lesion to complete the scan.
Step 3
DermaSensor’s algorithm analyzes spectral data and delivers skin cancer risk results in seconds.
Learn more about How DermaSensor works in real clinical settings here
Ready to implement?
Real Results, Real Stories
Hear from Your Fellow Physicians Nationwide.
Miss Less Melanoma with Immediate, Non-Invasive Skin Cancer Risk Results
“I think this is a revolutionary new product that can help us aid in the management of safety and wellness for our patients. In that, we can highlight and see whether any areas, dark areas, could potentially be cancerous.”
Dr. Anthony Ceccacci, Madison Avenue Aesthetics
“Integrating DermaSensor’s innovative technology into our practice, we now offer enhanced skin cancer assessment capabilities in our community, ensuring timely referrals for our patients.”
Dr. Kevin Wong, Founder of PT Family Medicine
“If you have DermaSensor, in 15 or 30 seconds, you can advise your patient that this is something you are going to refer to a dermatologist, or keep an eye on it, and you can re-evaluate on their next visit.”
Dr. Paul Hart, Physician
“I mean, a lot of my patients are very complex. It’s like an internal medicine practice.
You just had to, you just have to get it into your brain that it’s available.”
Dr. Marcy Gooise, Montgomery Medical
“For me, it was a no-brainer to choose the device…it’s crucial to recognize that skin cancers do not always present the same way in people of color.”
Dr. Jessica Shepherd, MD, MBA, FACOG Renowned Gynecologist and Good Morning America Media Personality
“The beauty of the device is how simple it is… it is simple, easy, and straightforward.”
Dr. Brian Hollett, SHIFT | Concierge Primary Care in Chicago CMO
“The feedback from patients has been excellent…giving them peace of mind about their skin cancer risk.”
Join the Initiative to Close the Detection Gap
Primary care setting can often miss a significant number of possible skin cancers during routine checks. Empower your practice with a second set of eyes that acts with the confidence of a specialist, ensuring no suspicious lesion goes unnoticed.
FDA-cleared results in seconds
Reimbursement assistance available
Over 10 years of clinical research and thousands of scanned lesions
Advanced AI & Optical Spectroscopy in the Palm of Your Hand
Proven Clinical Utility
The DermaSensor device uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. Our proprietary algorithms, developed and refined over a decade of clinical research, are trained on thousands of diagnosed lesions to help you make better informed decisions.
15 development, validation, and clinical utility studies to date with 5,000 lesions scanned and diagnosed*
DermaSensor’s™ tip reflects and records quick bursts of light off the lesion’s cellular and sub-cellular content.
The light is analyzed by the built-in computer to provide information to help physicians assess skin lesions (including melanomas, squamous cell carcinomas, and basal cell carcinomas) to aid in a
referral decision.
By examining the difference in light scattering, DermaSensor™ provides an immediate “Investigate Further” or
“Monitor,” output based on the lesion’s malignancy risk level.
Elastic Scattering Spectroscopy (ESS) has been validated in 30+ publications on clinical studies in various tissue types.Many studies have shown that ESS provides information that is comparable to histopathologic assessment in the analysis of cellular microscopic structure.
* Clinical evidence available upon request.
Who We Serve - FAQs
Who We Serve with DermaSensor - FAQs
What types of healthcare providers use DermaSensor?
DermaSensor is used by licensed healthcare providers who evaluate suspicious skin lesions, including family medicine physicians, internal medicine physicians, community health physicians, and practice managers. It is designed for point-of-care clinical use across a range of medical settings.
What clinical settings is DermaSensor used in?
DermaSensor is used in primary care, internal medicine, concierge practices, and health systems. It is designed for point-of-care use during routine patient visits where a clinician is evaluating a suspicious skin lesion.
How does DermaSensor support clinical skin cancer detection?
DermaSensor uses Elastic Scattering Spectroscopy (ESS) to assess tissue beneath the skin surface and provide an objective risk result. This gives clinicians additional information to support their evaluation of suspicious lesions and clinical decision-making.
Is DermaSensor different from a skin cancer detection app?
Yes. Consumer skin cancer apps use smartphone cameras to capture images of lesions. DermaSensor uses ESS technology to assess tissue beneath the skin surface and is FDA Cleared for clinical use – a fundamentally different standard from consumer image-based tools.
Can health systems deploy DermaSensor across multiple locations?
DermaSensor is designed to support consistent, point-of-care lesion assessment across multi-site clinical environments. It helps reduce diagnostic variability between providers and locations.
I am a patient. Where can I find a provider that uses DermaSensor?
You can locate clinics using DermaSensor through the DermaSensor Physician Finder. Search by ZIP code, city, or state to find a participating provider near you.
Take the Next Step
Advance Your Practice with AI-Powered Skin Cancer Detection in the Palm of your Hand!